Buchholz Richard's Form 4 filing
Inspire Medical Systems, Inc. (INSP) · filed Apr 5, 2022
- Accession no.
- 0001104659-22-042917
- Filed
- Apr 5, 2022
- Trade date
- Feb 17-Apr 1, 2022
- Filing delay
- 47 daysLate
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 10 non-derivative transactions. Open-market sales total $3.88M. It was filed 47 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Buchholz RichardCIK 0001737133 | Officer (Chief Financial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 17, 2022 | Common Stock | GGiftDisposed | −250 | $0.00 | $0 | 62,426 | Direct | |
| Feb 17, 2022 | Common Stock | GGiftAcquired | +125 | $0.00 | $0 | 1,125 | Indirect | |
| Feb 17, 2022 | Common Stock | GGiftAcquired | +125 | $0.00 | $0 | 1,125 | Indirect | |
| Feb 18, 2022 | Common Stock | GGiftDisposed | −250 | $0.00 | $0 | 62,176 | Direct | |
| Feb 18, 2022 | Common Stock | GGiftAcquired | +125 | $0.00 | $0 | 1,125 | Indirect | |
| Feb 18, 2022 | Common Stock | GGiftAcquired | +125 | $0.00 | $0 | 1,125 | Indirect | |
| Apr 1, 2022 | Common Stock | SSaleDisposed | −5,500 | $259.46F3 | −$1,427,030 | 56,676 | Direct | |
| Apr 1, 2022 | Common Stock | SSaleDisposed | −5,362 | $258.50F4 | −$1,386,077 | 51,314 | Direct | |
| Apr 1, 2022 | Common Stock | SSaleDisposed | −4,037 | $257.90F5 | −$1,041,142.3 | 47,277 | Direct | |
| Apr 1, 2022 | Common Stock | SSaleDisposed | −101 | $255.99 | −$25,854.99 | 47,176 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F3
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $259.10 to $259.675. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Referenced by the price of 1 transaction in Table I.
- F4
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $258.04 to $259.01. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Referenced by the price of 1 transaction in Table I.
- F5
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $257.04 to $258.03. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Referenced by the price of 1 transaction in Table I.